Corcept Therapeutics Announces Audited Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

$CORT (-1,57%)

Sales of USD 675.0 million in 2024, an increase of 40 percent compared to 2023

Sales forecast for 2025: USD 900 - 950 million

Net profit of USD 141.2 million in 2024, an increase of 33% compared to 2023

Cash and investments of USD 603.2 million as at December 31, 2024

https://www.businesswire.com/news/home/20250226825813/en/Corcept-Therapeutics-Announces-Fourth-Quarter-and-Full-Year-2024-Audited-Financial-Results-and-Provides-Corporate-Update